urovo(SZ:300531)2024-10-28 08:51Financial Performance - The company's revenue for Q3 2024 was ¥309,710,691.65, a decrease of 0.85% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2024 was ¥14,616,019.48, down 56.18% year-over-year[3]. - The net profit after deducting non-recurring gains and losses was ¥4,684,877.22, a decline of 83.53% compared to the previous year[3]. - The total operating revenue for Q3 2024 was CNY 935,304,312, an increase of 1.8% compared to CNY 920,602,594 in the same period last year[20]. - The net profit for Q3 2024 was CNY 17,405,647, a decrease of 78.9% compared to CNY 82,560,352 in Q3 2023[21]. - Basic earnings per share for Q3 2024 were CNY 0.05, down from CNY 0.25 in Q3 2023[21]. Cash Flow - The company reported a significant decrease in cash flow from operating activities, with a net cash flow of ¥2,587,732.83, down 96.08% year-over-year[3]. - The net cash flow from operating activities dropped by 96.08% to ¥2.59 million, primarily due to increased procurement payments[11]. - The cash inflow from operating activities for the current period was CNY 1,119,872,338.50, an increase from CNY 1,073,796,678.16 in the previous period, representing a growth of approximately 4.3%[22]. - The net cash flow from operating activities decreased significantly to CNY 2,587,732.83 from CNY 65,975,594.56 in the previous period, indicating a decline of over 96%[22]. - Cash inflow from investment activities was CNY 813,191,869.90, down from CNY 1,093,500,602.53, reflecting a decrease of about 25.6%[22]. - The net cash flow from investment activities improved to CNY 63,888,511.62 from a negative CNY 350,678,164.63, marking a turnaround[22]. - The cash paid for purchasing goods and services increased to CNY 787,387,642.78 from CNY 687,661,907.41, reflecting an increase of about 14.5%[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,332,381,331.51, a decrease of 0.53% from the end of the previous year[3]. - The total assets as of the end of Q3 2024 were CNY 2,332,381,331, a slight decrease from CNY 2,344,759,672 at the end of Q2 2024[19]. - The total liabilities increased to CNY 827,049,521.96 in Q3 2024, compared to CNY 796,724,959.43 in Q2 2024[19]. - The equity attributable to shareholders decreased by 2.76% to ¥1,504,065,515.42 compared to the end of the previous year[3]. - The equity attributable to shareholders of the parent company decreased to CNY 1,504,065,515.42 from CNY 1,546,712,855.20 in the previous quarter[19]. Research and Development - R&D investment increased by 11.35% compared to the previous year, reflecting the company's commitment to new technology and product development[6]. - The R&D expenses for Q3 2024 were CNY 94,603,853, an increase of 11.0% from CNY 84,959,266 in the previous year[20]. Market and Shareholder Information - The company's total number of ordinary shareholders reached 32,267, with the largest shareholder holding 34.40% of the shares[12]. - The company completed a share buyback program, with the announcement made on August 1, 2024[16]. Other Financial Metrics - The company's financial expenses increased by ¥26,380,000 due to exchange rate fluctuations and increased borrowing costs[8]. - The company's financial expenses surged by 108.43% to ¥2.05 million, influenced by exchange rate fluctuations and increased borrowing costs[9]. - The investment income turned negative at -¥60.48 million, a decline of 4,221.21% due to the disposal of derivative financial instruments[9]. - The company's other comprehensive income improved by 156.79% to ¥68.77 thousand, mainly due to the impact of exchange rate changes[9].